Literature DB >> 25434651

Decreased delta sleep ratio and elevated alpha power predict vulnerability to depression during interferon-alpha treatment.

Francis E Lotrich1, Anne Germain1.   

Abstract

OBJECTIVE: Although poor sleep accompanies depression, it is unknown which specific sleep abnormalities precede depression. This is similarly the case for depression developing during interferon-α (IFN-α) therapy. Because vulnerability becomes evident in those who slept poorly before IFN-α, we prospectively determined which specific aspect of sleep could predict subsequent depression.
METHODS: Two nights of polysomnography with quantitative electroencephalogram (EEG) were obtained in 24 adult, euthymic subjects--all subsequently treated with IFN-α for hepatitis C. Every 2 weeks, a Beck Depression Inventory-II (BDI-II) score was obtained, and the maximal increase in BDI-II from pre-treatment baseline--excluding the sleep question--was determined.
RESULTS: The delta sleep ratio (DSR; an index of early-night restorative delta power) was inversely associated with BDI-II increases (p<0.01), as was elevated alpha power (8-12 Hz; p<0.001). Both delta (0.5-4 Hz) and alpha power exhibited high between-night correlations (r=0.83 and 0.92, respectively). In mixed-effect repeated-measure analyses, there was an interaction between alpha power and DSR (p<0.001)--subjects with low alpha power and elevated DSR were resilient to developing depression. Most other sleep parameters--including total sleep time and percentage of time in slow wave sleep--were not associated with subsequent changes in depression.
CONCLUSIONS: Both high DSR and low alpha power may be specific indices of resilience. As most other aspects of sleep were not associated with resilience or vulnerability, sleep interventions to prevent depression may need to specifically target these specific sleep parameters.

Entities:  

Keywords:  sleep

Mesh:

Substances:

Year:  2014        PMID: 25434651     DOI: 10.1017/neu.2014.30

Source DB:  PubMed          Journal:  Acta Neuropsychiatr        ISSN: 0924-2708            Impact factor:   3.403


  7 in total

1.  Neurophysiological correlates of suicidal ideation in major depressive disorder: Hyperarousal during sleep.

Authors:  Michael R Dolsen; Philip Cheng; J Todd Arnedt; Leslie Swanson; Melynda D Casement; Hyang Sook Kim; Jennifer R Goldschmied; Robert F Hoffmann; Roseanne Armitage; Patricia J Deldin
Journal:  J Affect Disord       Date:  2017-01-26       Impact factor: 4.839

Review 2.  An Integrated Model of Slow-Wave Activity and Neuroplasticity Impairments in Major Depressive Disorder.

Authors:  Jennifer R Goldschmied; Philip Gehrman
Journal:  Curr Psychiatry Rep       Date:  2019-03-18       Impact factor: 5.285

3.  Sleep disturbance in substance use disorders and comorbid chronic viral infections.

Authors:  Jennifer M Loftis; Miranda M Lim
Journal:  Addiction       Date:  2016-06       Impact factor: 6.526

4.  Effects of slow-wave activity on mood disturbance in major depressive disorder.

Authors:  Jennifer R Goldschmied; Philip Cheng; Robert Hoffmann; Elaine M Boland; Patricia J Deldin; Roseanne Armitage
Journal:  Psychol Med       Date:  2018-05-29       Impact factor: 7.723

5.  Polyunsaturated fatty acids moderate the effect of poor sleep on depression risk.

Authors:  Francis E Lotrich; Barry Sears; Robert K McNamara
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2015-11-10       Impact factor: 4.006

Review 6.  Sleep Health: Reciprocal Regulation of Sleep and Innate Immunity.

Authors:  Michael R Irwin; Mark R Opp
Journal:  Neuropsychopharmacology       Date:  2016-08-11       Impact factor: 7.853

7.  Brain arousal regulation and depressive symptomatology in adults with attention-deficit/hyperactivity disorder (ADHD).

Authors:  Jue Huang; Christine Ulke; Maria Strauss
Journal:  BMC Neurosci       Date:  2019-08-20       Impact factor: 3.288

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.